Ephedrine Sulfate in 0 — Class II drug recall D-1064-2017
Terminated recall by Cantrell Drug Company, reported 2017-08-16, distributed nationwide. Lack of Sterility Assurance.
| Recall number | D-1064-2017 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Cantrell Drug Company, Little Rock, AR, United States |
| Recall initiated | 2017-07-14 |
| Classified | 2017-08-09 |
| Reported by FDA | 2017-08-16 |
| Terminated | 2020-09-16 |
| Distributed | Nationwide (US) |
| Quantity | 49,666 syringes |
| Reason classes | sterility |
| NDC | 52533-0118-15 |
| Lot numbers | 10004, 10043, 10088, 10115, 10269, 10431, 10554, 9904, 9914, 9939, 9952, 9969 |
| Expiration dates | 2017-07-28, 2017-08-04, 2017-08-17, 2017-09-08, 2017-09-23, 2017-10-27 |
Product
Ephedrine Sulfate in 0.9% Sodium Chloride 5 mL, 50 mg/5 mL (10 mg/mL) Single-Dose Syringe, Rx Only, Cantrell Drug Company 7321 Cantrell Rd Little Rock, AR 72207 877-666-5222, NDC 52533-118-15
Reason for recall
Lack of Sterility Assurance.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-1064-2017. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.